Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C08CA09

CAS registry number (Chemical Abstracts Service)

0103890-78-4

Chemical Formula

C26-H33-N-O6

Molecular Weight

346

Therapeutic Categories

Antihypertensive agent

Calcium channel blocker

Chemical Name

3,-5-Pyridinedicarboxilic acid,4-[2-[3-(1,1-dimetyletoxy)-3-oxo-1-propenyl]phenyl]-1,4-dihydro-2,6-dimetyl-,dietyl ester, (E)-

Foreign Names

• Lacidipinum (Latin)
• Lacidipin (German)
• Lacidipine (French)
• Lacidipino (Spanish)

Generic Names

• Lacidipina (OS: DCIT)
• Lacidipine (OS: USAN, DCF, BAN, JAN)
• GR 43659 X (Glaxo) (IS)
• GX 1048 (Glaxo) (IS)
• Lacidipine (PH: BP 2018)

Brand Names

• Aponil
  Glaxo Allen, Italy
• Lacibloc
  Ultramed, Philippines
• Lacicard
  Aristopharma, Bangladesh
• Lacidac
  Delta Pharma, Egypt
• Lacidipin Belupo
  Belupo, Croatia (Hrvatska)
• Lacidipin Double-E Pharma
  Copharma, Denmark
• Lacidipin Teva
  Teva, Denmark; Teva, Lithuania
• Lacidipina Rivopharm
  Rivopharm, Italy
• Lacidipine
  Doc Generici, Malta; Dr. Reddy's, United Kingdom; Rivopharm UK, United Kingdom
• Lacidipine Double-E Pharma
  Alpha-Medical, Croatia (Hrvatska); Double-E Pharma, Lithuania; Double-E Pharma Limited, Netherlands
• Lacidipine Teva
  Teva Nederland, Netherlands; Teva Pharmaceuticals, Poland
• Lacidipino Teva
  Teva, Spain
• Lacimen
  GlaxoSmithKline, Spain
• Lacipil
  Glaxo, Bulgaria; Glaxo Group, Romania; Glaxo Wellcome, Portugal; GlaxoSmithKline, Bulgaria; GlaxoSmithKline, Estonia; GlaxoSmithKline, Egypt; GlaxoSmithKline, Spain; GlaxoSmithKline, Georgia; GlaxoSmithKline, Hong Kong; GlaxoSmithKline, Croatia (Hrvatska); GlaxoSmithKline, Italy; GlaxoSmithKline, Lithuania; GlaxoSmithKline, Latvia; GlaxoSmithKline, Mexico; GlaxoSmithKline, Malaysia; GlaxoSmithKline, Philippines; GlaxoSmithKline, Poland; GlaxoSmithKline, Turkey; GlaxoSmithKline, Taiwan; GlaxoSmithKline, Venezuela; GlaxoSmithKline A.B.E.E., Greece; GlaxoSmithKline Brasil, Brazil; GSK, Czech Republic; GSK, Slovakia; Wellcome Limited, Bosnia & Herzegowina; GlaxoSmithKline China Investment, China
• Lacipil 2 mg
  GlaxoSmithKline, Hungary
• Lacipil 4 mg
  GlaxoSmithKline, Hungary
• Lacirex
  Laboratori Guidotti, Italy
• Lacitens
  GlaxoSmithKline A.B.E.E., Greece
• Lacivas
  Sun, India
• Lacydyna
  Alpha-Medical, Croatia (Hrvatska); Rivopharm, Poland
• Ladip
  Glaxo Allen, Italy
• Lanidiem
  Samil, South Korea
• Lapixen
  Biofarm, Poland
• Lasyn
  Synmosa, Taiwan
• Lodipine
  Egyphar, Egypt
• Midotens
  Boehringer Ingelheim, Mexico
• Monopin
  Pliva, Bosnia & Herzegowina; Pliva, Croatia (Hrvatska)
• Motens
  Boehringer Ingelheim, Greece; Boehringer Ingelheim España, Spain; GlaxoSmithKline UK, United Kingdom
• Prelum
  double-e pharma, Latvia
• Sileping
  Hayao Pharmaceutical Group Holding, China
• Sinopil
  GlaxoSmithKline, India
• Viapres
  Crinos, Italy

Glossary

Further information on drug naming conventions: International Nonproprietary Names.